Article (Scientific journals)
First study of oral artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers
Jansen, Frans Herwig; Adoubi, Innocent; Kouassi, Comoe J.C. et al.
2011In Anticancer Research, 31 (12), p. 4417-4422
Peer Reviewed verified by ORBi
 

Files


Full Text
artenimol.pdf
Publisher postprint (376.12 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
cervical cancer; artesunate; artenimol; clinical symptoms; tumor markers
Abstract :
[en] Background/Aim: Artenimol-R is cytotoxic in transformed cervical cells and safety in humans is yet to be established. The present study investigates the clinical benefits, safety and the tumor marker effect of orally administered Artenimol-R in patients with advanced cervix carcinoma. Patients and Methods: Ten patients were treated with Artenimol-R for 28 days. Clinical symptoms, vaginal discharge and pain were followed-up. Adverse events were recorded. Biopsy samples were analyzed by immunohistochemistry for the expression of relevant tumor markers. Results: Artenimol-R treatment induced clinical remission with a median time for the disappearance of the symptoms being 7 days. No adverse events of grade 3 or 4 occurred. The expression of p53, Epidermal growth factor receptor (EGFR), and antigen Ki-67 as a cellular marker of proliferation, as well as the number of blood vessels stained by the CD31 antibody decreased, whereas the expression of transferrin receptor protein 1 (CD71) increased. Conclusion: The current pilot study provides evidence on the improvement of the clinical symptoms and the good tolerability of Artenimol-R in patients with advanced carcinoma of the cervix uteri. A survival trial with Artenimol- R in advanced patients is warranted.
Disciplines :
Oncology
Author, co-author :
Jansen, Frans Herwig
Adoubi, Innocent
Kouassi, Comoe J.C.
De Cnodder, Tine
JANSEN, Nicolas ;  Centre Hospitalier Universitaire de Liège - CHU > Radiothérapie
Tschulakow, Alexander
Efferth, Thomas
Language :
English
Title :
First study of oral artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers
Publication date :
2011
Journal title :
Anticancer Research
ISSN :
0250-7005
eISSN :
1791-7530
Publisher :
JG Delinassios Anticancer Research, Athens, Greece
Volume :
31
Issue :
12
Pages :
4417-4422
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 03 January 2012

Statistics


Number of views
88 (2 by ULiège)
Number of downloads
1 (1 by ULiège)

Scopus citations®
 
88
Scopus citations®
without self-citations
53

Bibliography


Similar publications



Contact ORBi